Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12188/23076
DC FieldValueLanguage
dc.contributor.authorAli Memed, Ojaen_US
dc.contributor.authorHadzieva-Gigovska, Majaen_US
dc.contributor.authorKuneski, Dejanen_US
dc.contributor.authorTrajanovska, Eleonoraen_US
dc.contributor.authorAntovska, Packaen_US
dc.contributor.authorUgarkovic, Sonjaen_US
dc.contributor.authorSimonoska Crcarevska, Majaen_US
dc.contributor.authorGlavas Dodov, Marijaen_US
dc.date.accessioned2022-09-23T09:42:50Z-
dc.date.available2022-09-23T09:42:50Z-
dc.date.issued2020-10-29-
dc.identifier.urihttp://hdl.handle.net/20.500.12188/23076-
dc.publisherMacedonian Pharmaceutical Associationen_US
dc.relation.ispartofMacedonian Pharmaceutical Bulletinen_US
dc.titleFormulation development of prolonged-release matrix tablets - factors influencing drug dissolution rateen_US
dc.typeArticleen_US
dc.identifier.doi10.33320/maced.pharm.bull.2020.66.03.063-
dc.identifier.urlhttp://bulletin.mfd.org.mk/volumes/Volume%2066_3/66_3_063.pdf-
dc.identifier.volume66-
dc.identifier.issue03-
item.grantfulltextnone-
item.fulltextNo Fulltext-
Appears in Collections:Faculty of Pharmacy: Journal Articles
Show simple item record

Page view(s)

50
checked on Jul 17, 2024

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.